申请人:Hoffmann-La Roche Inc.
公开号:US06187905B1
公开(公告)日:2001-02-13
The invention relates to &agr;-ketoamides of the general formula
wherein R1 to R12 have the significances given in the description, and their salts. The &agr;-ketoamide derivatives provided by the present invention inhibit proteinases of viral origin, such as HCV protease, and can be used in the treatment of viral infections, especially viral infections caused by hepatitis C, hepatitis G and human GB viruses.
该发明涉及通式中R1至R12具有描述中给出的含义及其盐的α-酮酰胺。本发明提供的α-酮酰胺衍生物抑制病毒性蛋白酶,如HCV蛋白酶,并可用于治疗病毒感染,特别是由丙型肝炎病毒、丙型肝炎病毒和人类GB病毒引起的病毒感染。